CFH Y402H confers similar risk of soft drusen and both forms of advanced AMD

PLoS Medicine

Volumn 3, Issue 1, 2006, Pages 109-114

  Magnusson, Kristinn P ^a   Duan, Shan ^b,c   Sigurdsson, Haraldur ^d,e   Petursson, Hjorvar ^a   Yang, Zhenglin ^b,f   Zhao, Yu ^b   Bernstein, Paul S ^b   Ge, Jian ^c   Jonasson, Fridbert ^d,e   Stefansson, Einar ^d,e   Helgadottir, Gudleif ^d   Zabriskie, Norman A ^b   Jonsson, Thorlakur ^a   Björnsson, Asgeir ^a   Thorlacius, Theodora ^a   Jonsson, Palmi V ^d   Thorleifsson, Gudmar ^a   Kong, Augustine ^a   Stefansson, Hreinn ^a   Zhang, Kang ^b   Stefansson, Kari ^a   Gulcher, Jeffrey R ^a   more..

^a DECODE GENETICS   (Iceland)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^c SUN YAT SEN UNIVERSITY   (China)

^d LANDSPITALI UNIVERSITY HOSPITAL   (Iceland)

^e UNIVERSITY OF ICELAND   (Iceland)

^f SICHUAN PROVINCIAL PEOPLE'S HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; COMPLEMENT FACTOR H; COMPLEMENT FACTOR H, HUMAN;

ARTICLE; COHORT ANALYSIS; COMPLEMENT SYSTEM; CONTROLLED STUDY; DISEASE CLASSIFICATION; DISEASE SEVERITY; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE ENVIRONMENT INTERACTION; GENOTYPE PHENOTYPE CORRELATION; GEOGRAPHIC DISTRIBUTION; GEOGRAPHICAL ATROPHY AGE RELATED MACULAR DEGENARATION; HUMAN; ICELAND; MAJOR CLINICAL STUDY; NEOVASCULAR AGE RELATED MACULAR DEGENERATION; RETINA MACULA AGE RELATED DEGENERATION; RETINA MACULOPATHY; SOFT DRUSEN; UNITED STATES; VISUAL IMPAIRMENT; DRUSEN; GENETIC PREDISPOSITION; GENETICS; MUTATION; RETINA MACULA DEGENERATION; RISK; RISK FACTOR;

COMPLEMENT FACTOR H; GENETIC PREDISPOSITION TO DISEASE; HUMANS; ICELAND; MACULAR DEGENERATION; MUTATION; ODDS RATIO; RETINAL DRUSEN; RISK FACTORS; UTAH;

EID: 32044474231     PISSN: 15491277     EISSN: None     Source Type: Journal    
DOI: 10.1371/journal.pmed.0030005     Document Type: Article

References (37)

1. Fine SL, Martin DF, Kirkpatrick P (2005) Pegaptanib sodium. Nat Rev Drug Discov 4: 187-188.
2. Hageman GS, Luthert PJ, Victor Chong NH, Johnson LV, Anderson DH, et al. (2001) An integrated hypothesis that considers drusen as biomarkers of immune-mediated processes at the RPE-Bruch's membrane interface in aging and age-related macular degeneration. Prog Retin Eye Res 20: 705-732.
3. Hageman GS, Anderson DH, Johnson LV, Hancox LS, Taiber AJ, et al. (2005) A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration. Proc Natl Acad Sci U S A 102: 7227-7232
4. Mullins RF, Russell SR, Anderson DH, Hageman GS (2000) Drusen associated with aging and age-related macular degeneration contain proteins common to extracellular deposits associated with atherosclerosis, elastosis, amyloidosis, and dense deposit disease. Faseb J 14: 835-846.
5. Mullins RF, Aptsiauri N, Hageman GS (2001) Structure and composition of drusen associated with glomerulonephritis: Implications for the role of complement activation in drusen biogenesis. Eye 15: 390-395.
6. Anderson DH, Mullins RF, Hageman GS, Johnson LV (2002) A role for local inflammation in the formation of drusen in the aging eye. Am J Ophthalmol 134: 411-431.
7. Johnson LV, Leitner WP, Staples MK, Anderson DH (2001) Complement activation and inflammatory processes in drusen formation and age related macular degeneration. Exp Eye Res 73: 887-896.
8. Crabb JW, Miyagi M, Gu X, Shadrach K, West KA, et al. (2002) Drusen proteome analysis: An approach to the etiology of age-related macular degeneration. Proc Natl Acad Sci U S A 99: 14682-14687.
9. Klein ML, Schultz DW, Edwards A, Matise TC, Rust K, et al. (1998) Agerelated macular degeneration. Clinical features in a large family and linkage to chromosome 1q. Arch Ophthalmol 116: 1082-1088.
10. Weeks DE, Conley YP, Tsai HJ, Mah TS, Rosenfeld PJ, et al. (2001) Age-related maculopathy: An expanded genome-wide scan with evidence of susceptibility loci within the 1q31 and 17q25 regions. Am J Ophthalmol 132: 682-692.
11. Majewski J, Schultz DW, Weleber RG, Schain MB, Edwards AO, et al. (2003) Age-related macular degeneration - A genome scan in extended families. Am J Hum Genet 73: 540-550.
12. Seddon JM, Santangelo SL, Book K, Chong S, Cote J (2003) A genomewide scan for age-related macular degeneration provides evidence for linkage to several chromosomal regions. Am J Hum Genet 73: 780-790.
13. Schmidt S, Scott WK, Postel EA, Agarwal A, Hauser ER, et al. (2004) Ordered subset linkage analysis supports a susceptibility locus for agerelated macular degeneration on chromosome 16p12. BMC Genet 5: 18.
14. Abecasis GR, Yashar BM, Zhao Y, Ghiasvand NM, Zareparsi S, et al. (2004) Age-related macular degeneration: A high-resolution genome scan for susceptibility loci in a population enriched for late-stage disease. Am J Hum Genet 74: 482-494.
15. Iyengar SK, Song D, Klein BE, Klein R, Schick JH, et al. (2004) Dissection of genomewide-scan data in extended families reveals a major locus and oligogenic susceptibility for age-related macular degeneration. Am J Hum Genet 74: 20-39.
16. Edwards AO, Ritter R 3rd, Abel KJ, Manning A, Panhuysen C, et al. (2005) Complement factor H polymorphism and age-related macular degeneration. Science 308: 421-424.
17. Haines JL, Hauser MA, Schmidt S, Scott WK, Olson LM, et al. (2005) Complement factor H variant increases the risk of age-related macular degeneration. Science 308: 419-421.
18. Klein RJ, Zeiss C, Chew EY, Tsai JY, Sackler RS, et al. (2005) Complement factor H polymorphism in age-related macular degeneration. Science 308: 385-389.
19. Zareparsi S, Branham KE, Li M, Shah S, Klein RJ, et al. (2005) Strong association of the Y402H variant in complement factor H at 1q32 with susceptibility to age-related macular degeneration. Am J Hum Genet 77: 149-153.
20. Giannakis E, Jokiranta TS, Male DA, Ranganathan S, Ormsby RJ, et al. (2003) A common site within factor H SCR 7 responsible for binding heparin, C-reactive protein and streptococcal M protein. Eur J Immunol 33: 962-969.
21. Gulcher JR, Kristjansson K, Gudbjartsson H, Stefansson K (2000) Protection of privacy by third-party encryption in genetic research in Iceland. Eur J Hum Genet 8: 739-742.
22. Morris JN, Hawes C, Fries BE, Phillips CD, Mor V, et al. (1990) Designing the national resident assessment instrument for nursing homes. Gerontologist 30: 293-307.
23. Bird AC, Bressler NM, Bressler SB, Chisholm IH, Coscas G, et al. (1995) An international classification and grading system for age-related maculopathy and age-related macular degeneration. The International ARM Epidemiological Study Group. Surv Ophthalmol 39: 367-374.
24. Risch N, Teng J (1998) The relative power of family-based and case-control designs for linkage disequilibrium studies of complex human diseases I. DNA pooling. Genome Res 8: 1273-1288.
25. Terwilliger JD, Ott J (1992) A haplotype-based "haplotype relative risk" approach to detecting allelic associations. Hum Hered 42: 337-346.
26. Falk CT, Rubinstein P (1987) Haplotype relative risks: An easy reliable way to construct a proper control sample for risk calculations. Ann Hum Genet 51: 227-233.
27. Consortium TIH (2003) The International HapMap Project. Nature 426: 789-796.
28. Jonasson F, Arnarsson A, Sasaki H, Peto T, Sasaki K, et al. (2003) The prevalence of age-related maculopathy in iceland: Reykjavik eye study. Arch Ophthalmol 121: 379-385.
29. Jonasson F, Arnarsson A, Peto T, Sasaki H, Sasaki K, et al. (2005) 5-year incidence of age-related maculopathy in the Reykjavik Eye Study. Ophthalmology 112: 132-138.
30. Klein R, Klein BE, Tomany SC, Meuer SM, Huang GH (2002) Ten-year incidence and progression of age-related maculopathy: The Beaver Dam eye study. Ophthalmology 109: 1767-1779.
31. Mitchell P, Smith W, Attebo K, Wang JJ (1995) Prevalence of age-related maculopathy in Australia. The Blue Mountains Eye Study. Ophthalmology 102: 1450-1460.
32. Seddon JM, Rosner B, Sperduto RD, Yannuzzi L, Haller JA, et al. (2001) Dietary fat and risk for advanced age-related macular degeneration. Arch Ophthalmol 119: 1191-1199.
33. Klein R, Peto T, Bird A, Vannewkirk MR (2004) The epidemiology of agerelated macular degeneration. Am J Ophthalmol 137: 486-495.
34. Friedman DS, Katz J, Bressler NM, Rahmani B, Tielsch JM (1999) Racial differences in the prevalence of age-related macular degeneration: The Baltimore Eye Survey. Ophthalmology 106: 1049-1055.
35. Leske MC, Wu SY, Hyman L, Hennis A, Nemesure B, et al. (2004) Four-year incidence of macular changes in the Barbados Eye Studies. Ophthalmology 111: 706-711.
36. Hammond CJ, Webster AR, Snieder H, Bird AC, Gilbert CE, et al. (2002) Genetic influence on early age-related maculopathy: A twin study. Ophthalmology 109: 730-736.
37. Seddon JM, Cote J, Page WF, Aggen SH, Neale MC (2005) The US twin study of age-related macular degeneration: Relative roles of genetic and environmental influences. Arch Ophthalmol 123: 321-327.